Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Point of Care Infectious Disease Testing Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Point of Care Infectious Disease Testing Market: End-Use Insights
4.1. Global End-Use Historic Market Data & Future Forecasts, 2016-2027
4.2. Hospitals
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Clinics
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Home
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Assisted Living Healthcare Facilities
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Laboratories
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.7. Others
4.7.1. Historic Market Data & Future Forecasts, 2016-2027
4.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Point of Care Infectious Disease Testing Market: Testing Disease Insights
5.1. Global Testing Disease Historic Market Data & Future Forecasts, 2016-2027
5.2. HIV POC
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Clostridium difficile POC
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. HBV POC
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Pneumonia or Streptococcus associated infections
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.6. Respiratory syncytial virus (RSV) POC
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.7. HPV POC
5.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.8. Influenza/Flu POC
5.8.1. Historic Market Data & Future Forecasts, 2016-2027
5.8.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.9. HCV POC
5.9.1. Historic Market Data & Future Forecasts, 2016-2027
5.9.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.10. Other infectious disease POC
5.10.1. Historic Market Data & Future Forecasts, 2016-2027
5.10.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Point of Care Infectious Disease Testing Market: Regional Insights
6.1. Global Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By End-Use, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Testing Disease, 2016-2027
Chapter 7. Company Profiles
7.1. Hoffmann-La Roche Ltd
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Thermo Fisher Scientific, Inc.
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Quest Diagnostics Inc
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Bio-Rad Laboratories, Inc.
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Abbott
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Cardinal Health
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. bioMérieux SA
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. Sight Diagnostics Ltd
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. Siemens Healthineers
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. Trinity Biotech
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives
List of Tables
Table 1 Point of Care Infectious Disease Testing MarketMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 4 Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 5 HospitalsMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 ClinicsMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Home Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Assisted Living Healthcare Facilities Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9Laboratories Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 HIV POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Clostridium difficile POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 HBV POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Pneumonia or Streptococcus associated infections Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Respiratory syncytial virus (RSV) POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 HPV POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 Influenza/Flu POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 HCV POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 19 Other infectious disease POC Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 20 North America Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 North America Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 22 North America Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 23 U.S. Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 24 U.S. Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 25 U.S. Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 26 Canada Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 27 Canada Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 28 Canada Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 29 Europe Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 30 Europe Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 31 Europe Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 32 U.K. Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 33 U.K Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 34 U.K Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 35 Germany Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 36 Germany Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 37 Germany Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 38 France Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 39 France Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 40 France Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 41 Asia Pacific Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 42 Asia Pacific Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 43 Asia Pacific Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 44 China Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 45 China Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 46 China Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 47 India Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 48 India Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 49 India Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 50 Japan Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 51 Japan Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 52 Japan Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 53 South Korea Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 54 South Korea Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 55 South Korea Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 56 Latin America Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 57 Latin America Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 58 Latin America Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 59 Brazil Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 60 Brazil Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 61 Brazil Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 62 Mexico Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 63 Mexico Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 63 Mexico Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 64 Middle East & Africa Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 65 Middle East & Africa Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 66 Middle East & Africa Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 67 UAE Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 68 UAE Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 69 UAE Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
Table 70 South Africa Point of Care Infectious Disease TestingMarket Data & Future Forecasts, 2016-2027 (USD Billion)
Table 71 South Africa Point of Care Infectious Disease TestingMarket Data & Future Forecasts, By End-Use, 2016-2027 (USD Billion)
Table 72 South Africa Point of Care Infectious Disease Testing Market Data & Future Forecasts, By Testing Disease, 2016-2027 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2Point of Care Infectious Disease Testing Market, by 2016-2027 (USD Billion)
Fig.3Point of Care Infectious Disease Testing Market Segmentation
Fig.4Supply chain analysis
Fig.5 Point of Care Infectious Disease Testing Market Driver Anlaysis
Fig.6 Point of Care Infectious Disease Testing Market Restraint Analysis
Fig.7 Point of Care Infectious Disease Testing Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Point of Care Infectious Disease Testing Market
Fig.10 Company Market Share Analysis, 2019
